"skipMainNavigation"
closeDrawerMenuopenDrawerMenu
Search
Quick Search in Journals
Quick Search anywhere
Advanced Search
Radiology
Menu
  • Information
    • Previous
    Next
    Breast Imaging

    Stereotactic Breast Biopsy of Nonpalpable Lesions: Determinants of Ductal Carcinoma in Situ Underestimation Rates

    Published Online:Feb 1 2001https://doi.org/10.1148/radiology.218.2.r01fe35497

    Abstract

    PURPOSE: To measure the effect of biopsy device, probe size, mammographic lesion type, lesion size, and number of samples obtained per lesion on the ductal carcinoma in situ (DCIS) underestimation rate.

    MATERIALS AND METHODS: Nonpalpable breast lesions at 16 institutions received a histologic diagnosis of DCIS after 14-gauge automated large-core biopsy in 373 lesions and after 14- or 11-gauge directional vacuum-assisted biopsy in 953 lesions. The presence of histopathologic invasive carcinoma was noted at subsequent surgical biopsy.

    RESULTS: By performing the χ2 test, independent significant DCIS underestimation rates by biopsy device were 20.4% (76 of 373) of lesions diagnosed at large-core biopsy and 11.2% (107 of 953) of lesions diagnosed at vacuum-assisted biopsy (P < .001); by lesion type, 24.3% (35 of 144) of masses and 12.5% (148 of 1,182) of microcalcifications (P < .001); and by number of specimens per lesion, 17.5% (88 of 502) with 10 or fewer specimens and 11.5% (92 of 799) with greater than 10 (P < .02). DCIS underestimations increased with lesion size.

    CONCLUSION: DCIS underestimations were 1.9 times more frequent with masses than with calcifications, 1.8 times more frequent with large-core biopsy than with vacuum-assisted biopsy, and 1.5 times more frequent with 10 or fewer specimens per lesion than with more than 10 specimens per lesion.

    References

    • 1 Jackman RJ, Nowels KW, Shepard MJ, Finkelstein SI, Marzoni FA. Stereotaxic large-core needle biopsy of 450 nonpalpable breast lesions with surgical correlation in lesions with cancer or atypical hyperplasia. Radiology 1994; 193:91-95. Link, Google Scholar
    • 2 Liberman L, Dershaw DD, Rosen PP, et al. Stereotaxic core biopsy of breast carcinoma: accuracy at predicting invasion. Radiology 1995; 194:379-381. Link, Google Scholar
    • 3 Nguyen M, McCombs MM, Ghandehari S, et al. An update on core needle biopsy for radiologically detected breast lesions. Cancer 1996; 78:2340-2345. Crossref, Medline, Google Scholar
    • 4 Burbank F. Stereotactic breast biopsy of atypical ductal hyperplasia and ductal carcinoma in situ lesions: improved accuracy with directional, vacuum-assisted biopsy. Radiology 1997; 202:843-847. Link, Google Scholar
    • 5 Acheson MB, Patton RG, Howisey RL, Lane RF, Morgan A. Histologic correlation of image-guided core biopsy with excisional biopsy of nonpalpable breast lesions. Arch Surg 1997; 132:815-821. Crossref, Medline, Google Scholar
    • 6 Fuhrman GM, Cederbom GJ, Bolton JS, et al. Image-guided core-needle breast biopsy is an accurate technique to evaluate patients with nonpalpable imaging abnormalities. Ann Surg 1998; 6:932-939. Google Scholar
    • 7 Meyer JE, Smith DN, Lester SC, et al. Large-core needle biopsy of nonpalpable breast lesions. JAMA 1999; 181:1638-1641. Google Scholar
    • 8 Won B, Reynolds HE, Lazaridis CL, Jackson VP. Stereotactic biopsy of ductal carcinoma in situ of the breast using an 11-gauge vacuum-assisted device: persistent underestimation of disease. AJR Am J Roentgenol 1999; 173:227-229. Crossref, Medline, Google Scholar
    • 9 Burbank F, Parker SH. Methods for evaluating the quality of an image-guided breast biopsy program. Semin Breast Dis 1998; 1:71-83. Google Scholar
    • 10 Lagios MD, Westdahl PR, Margolin FR, Rose MR. Duct carcinoma in situ: relationship of extent of noninvasive disease to the frequency of occult invasion, multicentricity, lymph node metastases, and short-term treatment failures. Cancer 1982; 50:1309-1314. Crossref, Medline, Google Scholar
    • 11 Silverstein MJ, Rosser RJ, Gierson ED, et al. Axillary lymph node dissection for intraductal breast carcinoma: is it indicated?. Cancer 1987; 59:1819-1824. Crossref, Medline, Google Scholar
    • 12 Wood WC. Should axillary dissection be performed in patients with DCIS? (editorial). Ann Surg Oncol 1995; 2:193-194. Crossref, Medline, Google Scholar
    • 13 Pandelidis SM, Peters KL, Walusimbi MS, et al. The role of axillary dissection in mammographically detected carcinoma. J Am Coll Surg 1997; 184:341-345. Medline, Google Scholar
    • 14 Morrow M. Axillary dissection: an obsolete operation?. Breast J 1998; 4:330-335. Crossref, Google Scholar
    • 15 Parker SH, Burbank F. A practical approach to minimally invasive breast biopsy. Radiology 1996; 200:11-20. Link, Google Scholar
    • 16 Burbank F, Parker SH, Fogarty TJ. Stereotactic breast biopsy: improved tissue harvesting with the Mammotome. Am Surg 1996; 62:738-744. Medline, Google Scholar
    • 17 Parker SH, Lovin JD, Jobe WE, et al. Stereotactic breast biopsy with a biopsy gun. Radiology 1990; 176:741-747. Link, Google Scholar
    • 18 Parker SH, Lovin JD, Jobe WE, Burke BJ, Hopper KD, Yakes WR. Nonpalpable breast lesions: stereotactic automated large-core biopsies. Radiology 1991; 180:403-407. Link, Google Scholar
    • 19 Elvecrog EL, Lechner MC, Nelson MT. Nonpalpable breast lesions: correlation of stereotaxic large-core needle biopsy and surgical biopsy results. Radiology 1993; 188:453-455. Link, Google Scholar
    • 20 Liberman L, Dershaw DD, Rosen PP, Abramson AF, Deutch BM, Hann LE. Stereotaxic 14-gauge breast biopsy: how many core specimens are needed?. Radiology 1994; 192:793-795. Link, Google Scholar
    • 21 Parker SH, Dennis MA, Stavros AT. Critical pathways in percutaneous breast intervention. RadioGraphics 1995; 15:946-950. Link, Google Scholar
    • 22 Parker SH, Stavros AT, Dennis MA. Needle biopsy techniques. Radiol Clin North Am 1995; 33:1171-1186. Medline, Google Scholar
    • 23 Burbank F. Stereotactic breast biopsy: its history, its present, and its future. Am Surg 1996; 62:128-150. Medline, Google Scholar
    • 24 Parker SH, Klaus AJ. Performing a breast biopsy with a directional, vacuum-assisted biopsy instrument. RadioGraphics 1997; 17:1233-1252. Link, Google Scholar
    • 25 Jackman RJ, Burbank F, Parker SH, et al. Atypical ductal hyperplasia diagnosed at stereotactic breast biopsy: improved reliability with 14-gauge, directional, vacuum-assisted biopsy. Radiology 1997; 204:485-488. Link, Google Scholar
    • 26 Liberman L, Smolkin JH, Dershaw DD, Morris EA, Abramson AF, Rosen PP. Calcification retrieval at stereotactic, 11-gauge, directional, vacuum-assisted breast biopsy. Radiology 1998; 208:251-260. Link, Google Scholar
    • 27 Liberman L, Vuolo M, Dershaw DD, et al. Epithelial displacement after stereotactic 11-gauge directional vacuum-assisted breast biopsy. AJR Am J Roentgenol 1999; 172:677-681. Crossref, Medline, Google Scholar
    • 28 Burbank F. Stereotactic breast biopsy: comparison of 14- and 11-gauge Mammotome probe performance and complication rates. Am Surg 1997; 63:988-995. Medline, Google Scholar
    • 29 Berg WA, Krebs TL, Campassi C, Magder LS, Sun CCJ. Evaluation of 14- and 11-gauge directional, vacuum-assisted biopsy probes and 14-gauge biopsy guns in a breast parenchymal model. Radiology 1997; 205:203-208. Link, Google Scholar
    • 30 Jackman RJ, Marzoni FA, Nowels KW. Percutaneous removal of benign mammographic lesions: comparison of automated large-core and directional vacuum-assisted stereotactic biopsy techniques. AJR Am J Roentgenol 1998; 171:1325-1330. Crossref, Medline, Google Scholar
    • 31 Liberman L, Cohen MA, Dershaw DD, Abramson AF, Hann LE, Rosen PP. Atypical ductal hyperplasia diagnosed at stereotaxic core biopsy of breast lesions: an indication for surgical biopsy. AJR Am J Roentgenol 1995; 164:1111-1113. Crossref, Medline, Google Scholar
    • 32 Dahlstrom JE, Jain S, Sutton T, Sutton S. Diagnostic accuracy of stereotactic core biopsy in a mammographic breast cancer screening programme. Histopathology 1996; 28:421-427. Crossref, Medline, Google Scholar
    • 33 Tocino I, Garcia BM, Carter D. Surgical biopsy findings in patients with atypical hyperplasia diagnosed by stereotaxic core needle biopsy. Ann Surg Oncol 1996; 3:483-488. Crossref, Medline, Google Scholar
    • 34 Moore MM, Hargett CW, Hanks JB, et al. Association of breast cancer with the finding of atypical ductal hyperplasia at core breast biopsy. Ann Surg 1997; 225:726-733. Crossref, Medline, Google Scholar
    • 35 Gadzala DE, Cederbom GJ, Bolton JS, et al. Appropriate management of atypical ductal hyperplasia diagnosed by stereotactic core needle breast biopsy. Ann Surg Oncol 1997; 4:283-286. Crossref, Medline, Google Scholar
    • 36 Brown TA, Wall JW, Christensen ED, et al. Atypical hyperplasia in the era of stereotactic core needle biopsy. J Surg Oncol 1998; 67:168-173. Crossref, Medline, Google Scholar
    • 37 Lee CH, Egglin TK, Philpotts L, Mainiero MB, Tocino I. Cost-effectiveness of stereotactic core needle biopsy: analysis by means of mammographic findings. Radiology 1997; 202:849-854. Link, Google Scholar
    • 38 Liberman L, Dershaw DD, Glassman JR, et al. Analysis of cancers not diagnosed at stereotactic core breast biopsy. Radiology 1997; 203:151-157. Link, Google Scholar
    • 39 Meyer JE, Smith DN, Lester SC, et al. Large-needle core biopsy: nonmalignant breast abnormalities evaluated with surgical excision or repeat core biopsy. Radiology 1998; 206:717-720. Link, Google Scholar
    • 40 Lin PH, Clyde JC, Bates DM, Garcia JM, Matsumoto GH, Girvin GW. Accuracy of stereotactic core-needle breast biopsy in atypical ductal hyperplasia. Am J Surg 1998; 175:380-382. Crossref, Medline, Google Scholar
    • 41 Jackman RJ, Nowels KW, Rodriguez-Soto J, Marzoni FA, Finkelstein SI, Shepard MJ. Stereotactic, automated, large-core needle biopsy of nonpalpable breast lesions: false-negative and histologic underestimation rates after long-term follow-up. Radiology 1999; 210:799-805. Link, Google Scholar
    • 42 Brem RF, Behrndt VS, Sanow L, Gatewood OMB. Atypical ductal hyperplasia: histologic underestimation of carcinoma in tissue harvested from impalpable breast lesions using 11-gauge stereotactically guided directional vacuum-assisted biopsy. AJR Am J Roentgenol 1999; 172:1405-1407. Crossref, Medline, Google Scholar
    • 43 Matthews BD, Williams GB. Initial experience with the Advanced Breast Biopsy Instrumentation system. Am J Surg 1999; 177:97-101. Crossref, Medline, Google Scholar
    • 44 Thompson WR, Bowen JR, Dorman BA, Pricolo VE, Shahinian TK, Soderberg CH. Mammographic localization and biopsy of nonpalpable breast lesions: a 5-year study. Arch Surg 1991; 126:730-734. Crossref, Medline, Google Scholar
    • 45 Tartter PI, Bleiweiss IJ, Levchenko S. Factors associated with clear biopsy margins and clear reexcision margins in breast cancer specimens from candidates for breast conservation. J Am Coll Surg 1997; 185:268-273. Crossref, Medline, Google Scholar
    • 46 American College of Radiology. Breast imaging reporting and data system (BI-RADS) 3rd ed. Reston, Va: American College of Radiology, 1998. Google Scholar

    Article History

    Published in print: Feb 2001